|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aguiar PN Jr, Tadokoro H, Forones NM and
de Mello RA: Treating operable patients with gastric cancer:
Macdonald's protocol versus adjuvant chemotherapy. Future Oncol.
11:2247–2249. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamamoto M, Sakaguchi Y, Matsuyama A,
Yoshinaga K, Tsutsui S and Ishida T: Surgery after preoperative
chemotherapy for patients with unresectable advanced gastric
cancer. Oncology. 85:241–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qiu HB, Zhang LY, Keshari RP, Wang GQ,
Zhou ZW, Xu DZ, Wang W, Zhan YQ and Li W: Relationship between H.
Pylori infection and clinicopathological features and prognosis of
gastric cancer. BMC Cancer. 10:3742010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhai YK, Pan YL, Niu YB, Li CR, Wu XL, Fan
WT, Lu TL, Mei QB and Xian CJ: The importance of the prenyl group
in the activities of osthole in enhancing bone formation and
inhibiting bone resorption in vitro. Int J Endocrinol.
2014:9219542014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yogesh HS, Chandrashekhar VM, Katti HR,
Ganapaty S, Raghavendra HL, Gowda GK and Goplakhrishna B:
Anti-osteoporotic activity of aqueous-methanol extract of Berberis
aristata in ovariectomized rats. J Ethnopharmacol. 134:334–338.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee WS, Lee EG, Sung MS and Yoo WH:
Kaempferol inhibits IL-1β-stimulated, RANKL-mediated
osteoclastogenesis via downregulation of MAPKs, c-Fos, and NFATc1.
Inflammation. 37:1221–1230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tyagi AM, Srivastava K, Singh AK, Kumar A,
Changkija B, Pandey R, Lahiri S, Nagar GK, Yadav DK, Maurya R, et
al: Formononetin reverses established osteopenia in adult
ovariectomized rats. Menopause. 19:856–863. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clardy J and Walsh C: Lessons from natural
molecules. Nature. 432:829–837. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tannock IF and Rotin D: Acid pH in tumors
and its potential for therapeutic exploitation. Cancer Res.
49:4373–4384. 1989.PubMed/NCBI
|
|
12
|
Helmlinger G, Yuan F, Dellian M and Jain
RK: Interstitial pH and pO2 gradients in solid tumors in vivo:
High-resolution measurements reveal a lack of correlation. Nat Med.
3:177–182. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yeo M, Kim DK, Kim YB, Oh TY, Lee JE, Cho
SW, Kim HC and Hahm KB: Selective induction of apoptosis with
proton pump inhibitor in gastric cancer cells. Clin Cancer Res.
10:8687–8696. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ke Y, Ning T and Wang B: Establishment and
characterization of a SV40 transformed human fetal gastric
epithelial cell line-GES-1. Zhonghua Zhong Liu Za Zhi. 16:7–10.
1994.(In Chinese). PubMed/NCBI
|
|
15
|
Kim N, Lee SH, Son JH, Lee JM, Kang MJ,
Kim BH, Lee JS, Ryu JK and Kim YT: Fisetin reduces cell viability
through up-regulation of phosphorylation of ERK1/2 in
cholangiocarcinoma cells. Anticancer Res. 36:6109–6116. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maher P, Dargusch R, Bodai L, Gerard PE,
Purcell JM and Marsh JL: ERK activation by the polyphenols fisetin
and resveratrol provides neuroprotection in multiple models of
Huntington's disease. Hum Mol Genet. 20:261–270. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Holm E, Hagmüller E, Staedt U,
Schlickeiser G, Günther HJ, Leweling H, Tokus M and Kollmar HB:
Substrate balances across colonic carcinomas in humans. Cancer Res.
55:1373–1378. 1995.PubMed/NCBI
|
|
18
|
Vaupel P, Kallinowski F and Okunieff P:
Blood flow, oxygen and nutrient supply, and metabolic
microenvironment of human tumors: A review. Cancer Res.
49:6449–6465. 1989.PubMed/NCBI
|
|
19
|
Fais S, De Milito A, You H and Qin W:
Targeting vacuolar H+-ATPases as a new strategy against cancer.
Cancer Res. 67:10627–10630. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Danial NN and Korsmeyer SJ: Cell death:
Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim EK and Choi EJ: Pathological roles of
MAPK signaling pathways in human diseases. Biochim Biophys Acta.
1802:396–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu P, Chen JM, Guo HM, Fan XP, Zhang XS,
Fan RX, Zheng SY, Wu RB, Xiao XJ, Huang HL, et al: Matrine inhibits
disturbed flow-enhanced migration via downregulation of ERK1/2-MLCK
signaling vascular smooth muscle cells. Ann Vasc Surg. 26:268–275.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ballif BA and Blenis J: Molecular
mechanisms mediating mammalian mitogen-activated protein kinase
(MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ.
12:397–408. 2001.PubMed/NCBI
|
